Primary Percutaneous Coronary Intervention (PCI) has significantly contributed to reducing the mortality of patients with ST segment elevation myocardial infarction (STEMI) even in cardiogenic shock and is now the standard of care in most of Japanese institutions. The Task Force on Primary PCI of the Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT) proposed an expert consensus document for the management of acute myocardial infarction (AMI) focusing on procedural aspects of primary PCI in 2018 and updated in 2022 (Ozaki et al. in Cardiovasc Interv Ther 33:178-203, 2018), (Ozaki et al. in Cardiovasc Interv Ther 37:1-34, 2022). Following the publication of the 2023 European Society of Cardiology (ESC) Guidelines for the management of acute coronary syndromes, the CVIT Task Force released another revised version in 2024 (Ozaki et al. in Cardiovasc Interv Ther 39:335-375, 2024). In light of new clinical evidence and technological advances that have emerged since then, the Task Force now proposes an updated expert consensus document for the management of ACS focusing on procedural aspects of primary PCI in 2026 version.
初级经皮冠状动脉介入治疗(PCI)对降低ST段抬高型心肌梗死(STEMI)患者的死亡率有显著的贡献,即使是心源性休克,目前在大多数日本机构中都是标准的治疗方法。日本心血管干预和治疗协会(CVIT)初级PCI工作组于2018年提出了一份关于急性心肌梗死(AMI)管理的专家共识文件,重点关注初级PCI的程序方面,并于2022年更新(Ozaki et al. in Cardiovascular Interv Ther 33:18 - 203,2018), (Ozaki et al. in Cardiovascular Interv Ther 37:1- 34,2022)。随着2023年欧洲心脏病学会(ESC)急性冠状动脉综合征管理指南的发布,CVIT工作组于2024年发布了另一个修订版(Ozaki et al. in cardiovascular Interv Ther 39:35 - 375,2024)。鉴于自那时以来出现的新的临床证据和技术进步,工作组现在提出了一份更新的专家共识文件,用于ACS的管理,重点关注初级PCI的程序方面。
{"title":"CVIT expert consensus document on primary percutaneous coronary intervention (PCI) for acute coronary syndromes (ACS) in 2026.","authors":"Yukio Ozaki, Akihiro Tobe, Yoshinobu Onuma, Kotaro Miyashita, Yoshio Kobayashi, Tetsuya Amano, Kyohei Yamaji, Hideki Ishii, Takashi Muramatsu, Tevfik F Ismail, Shun Kohsaka, Yoshihisa Nakagawa, Yoshihiro Morino, Shiro Uemura, Kenichi Tsujita, Toshiro Shinke, Junya Ako, Junji Yajima, Yuichiro Maekawa, Junya Shite, Yasumi Igarashi, Nobuo Shiode, Atsunori Okamura, Takayuki Ogawa, Junichi Yamaguchi, Toshihiro Tamura, Takafumi Tsuji, Kentaro Hayashida, Teruyasu Sugano, Hiroyuki Okura, Hideki Okayama, Katsuhiro Kawaguchi, Kan Zen, Saeko Takahashi, Kazuhiko Nakazato, Nobuhiro Suematsu, Kiyoshi Hironaga, Tetsuya Matoba, Osamu Iida, Masaharu Ishihara, Masaya Ohta, Masahide Harada, Reina Ozaki, Hideo Izawa, Toyoaki Murohara, Takafumi Ueno, Masato Nakamura, Yuji Ikari, Patrick W Serruys, Ken Kozuma","doi":"10.1007/s12928-025-01229-z","DOIUrl":"https://doi.org/10.1007/s12928-025-01229-z","url":null,"abstract":"<p><p>Primary Percutaneous Coronary Intervention (PCI) has significantly contributed to reducing the mortality of patients with ST segment elevation myocardial infarction (STEMI) even in cardiogenic shock and is now the standard of care in most of Japanese institutions. The Task Force on Primary PCI of the Japanese Association of Cardiovascular Intervention and Therapeutics (CVIT) proposed an expert consensus document for the management of acute myocardial infarction (AMI) focusing on procedural aspects of primary PCI in 2018 and updated in 2022 (Ozaki et al. in Cardiovasc Interv Ther 33:178-203, 2018), (Ozaki et al. in Cardiovasc Interv Ther 37:1-34, 2022). Following the publication of the 2023 European Society of Cardiology (ESC) Guidelines for the management of acute coronary syndromes, the CVIT Task Force released another revised version in 2024 (Ozaki et al. in Cardiovasc Interv Ther 39:335-375, 2024). In light of new clinical evidence and technological advances that have emerged since then, the Task Force now proposes an updated expert consensus document for the management of ACS focusing on procedural aspects of primary PCI in 2026 version.</p>","PeriodicalId":9439,"journal":{"name":"Cardiovascular Intervention and Therapeutics","volume":" ","pages":""},"PeriodicalIF":5.8,"publicationDate":"2026-02-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147302625","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-25DOI: 10.1007/s12928-026-01257-3
Elke Boxhammer, Sophie Aglas, Nikolaus Clodi, Michael Lichtenauer, Richard Rezar, Christian Dinges, Christina Granitz, Crispiana Cozowicz, Uta C Hoppe, Matthias Hammerer
{"title":"Right heart function matters: prognostic value of sPAP, TAPSE and RV-PA coupling in a real-world cohort of TAVI patients.","authors":"Elke Boxhammer, Sophie Aglas, Nikolaus Clodi, Michael Lichtenauer, Richard Rezar, Christian Dinges, Christina Granitz, Crispiana Cozowicz, Uta C Hoppe, Matthias Hammerer","doi":"10.1007/s12928-026-01257-3","DOIUrl":"https://doi.org/10.1007/s12928-026-01257-3","url":null,"abstract":"","PeriodicalId":9439,"journal":{"name":"Cardiovascular Intervention and Therapeutics","volume":" ","pages":""},"PeriodicalIF":5.8,"publicationDate":"2026-02-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147281880","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-24DOI: 10.1007/s12928-026-01258-2
Go Kawamura, Shinsuke Kido, Go Hiasa, Hideki Okayama
{"title":"Incidental extraction of the chiari network following entrapment of a PFO occluder delivery system.","authors":"Go Kawamura, Shinsuke Kido, Go Hiasa, Hideki Okayama","doi":"10.1007/s12928-026-01258-2","DOIUrl":"https://doi.org/10.1007/s12928-026-01258-2","url":null,"abstract":"","PeriodicalId":9439,"journal":{"name":"Cardiovascular Intervention and Therapeutics","volume":" ","pages":""},"PeriodicalIF":5.8,"publicationDate":"2026-02-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"147281343","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-05DOI: 10.1007/s12928-026-01240-y
Tuan Xuan Ho, Linh My Thi Le, Son Van Nguyen, Bao The Nguyen
{"title":"Transthoracic echocardiography measurement versus balloon occlusive diameter for atrial septal defect: experience from a Vietnamese cohort (Vietnamese cohort: TTE vs balloon ASD sizing).","authors":"Tuan Xuan Ho, Linh My Thi Le, Son Van Nguyen, Bao The Nguyen","doi":"10.1007/s12928-026-01240-y","DOIUrl":"https://doi.org/10.1007/s12928-026-01240-y","url":null,"abstract":"","PeriodicalId":9439,"journal":{"name":"Cardiovascular Intervention and Therapeutics","volume":" ","pages":""},"PeriodicalIF":5.8,"publicationDate":"2026-02-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146123622","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-02-03DOI: 10.1007/s12928-025-01237-z
Lucas Barreiro Mesa, Martín Ruiz Ortiz, Alejandro Recio Mayoral, Alejandro Reina Moreno, Jaime Nevado Portero, Carlos Del Toro Esperón, Javier Torres Llergo, Ana María Martínez Rodríguez, Laura Jordán Martínez, Ismael Arco Adamuz, Aurora María Martínez Ballesta, Víctor Manuel López Espinosa, José Luis Delgado Prieto, Leopoldo Fernández Ruz, Ana Delia Ruiz Duthil, Cristina Cánovas Galindo, Sara Corpas Pérez, Alejando Isidoro Pérez Cabeza, Alberto Contreras Muñoz, Livia Gheorge, Mauricio Urgiles Ortiz, Marina Teresa García García, Jesús Aceituno Cubero, Gregorio Soto Rojas, Beatriz Girela Pérez, Sara Ballesteros Pradas, Virginia Pérez Ramírez, Almudena Valle Alberca, Susana Pérez Córdoba, José Javier Sánchez Fernández, Beatriz Calvo Bernal, Antonio Enrique Gómez Menchero, Carmen Lluch Requerey, Ana Del Río Lechuga, Juan José Serrano Silva, Rafael González González Manzanares, Dolores Mesa Rubio
There are no "real world" data on the actual impact of percutaneous left atrial appendage closure (LAAC) programs in the management of anticoagulated patients with atrial fibrillation (AF) after a hospital admission for bleeding. Our aim was to investigate the frequency, associated factors and prognostic impact of LAAC in the management of this population. All anticoagulated AF patients discharged alive from January 2021 to December 2022 after an intracranial or gastrointestinal haemorrhage, in the 15 public hospitals with LAAC program in Andalusia (South of Spain) were included in the study. Frequency, associated factors and prognostic impact of LAAC were investigated. Among a population of 7.119.044 inhabitants, 1403 patients were included (median age 81[p25-75, 76-87] years, 51.6% male). A LAAC procedure was performed in 114 patients (8.13%, 95%CI 6.70-9.56%) at 5 [2-10] months after discharge. LAAC was independently associated with tertiary referral centre, intracranial haemorrhage, previous bleeding, valvular heart disease, leukaemia and aspirin use while it was more infrequent in aged > 80 years, dementia, uncontrolled hypertension, vitamin K antagonist use and interventional treatment of the bleeding event (p < 0.05). After the procedure, the LAAC group had a better survival free from embolic/bleeding events and all-cause death (66% versus 49%) and overall survival (82% versus 64%) at 24 months (p < 0.05), consistent after multivariate adjustment: HR 0.65[0.46-0.92] and HR 0.52[0.32-0.86], respectively (p < 0.05). In our study, LAAC was infrequently performed after a severe bleeding in anticoagulated AF patients, although it was associated with better prognosis.
{"title":"Left atrial appendage closure after a hospital admission for bleeding in atrial fibrillation patients: frequency, associated factors and prognosis.","authors":"Lucas Barreiro Mesa, Martín Ruiz Ortiz, Alejandro Recio Mayoral, Alejandro Reina Moreno, Jaime Nevado Portero, Carlos Del Toro Esperón, Javier Torres Llergo, Ana María Martínez Rodríguez, Laura Jordán Martínez, Ismael Arco Adamuz, Aurora María Martínez Ballesta, Víctor Manuel López Espinosa, José Luis Delgado Prieto, Leopoldo Fernández Ruz, Ana Delia Ruiz Duthil, Cristina Cánovas Galindo, Sara Corpas Pérez, Alejando Isidoro Pérez Cabeza, Alberto Contreras Muñoz, Livia Gheorge, Mauricio Urgiles Ortiz, Marina Teresa García García, Jesús Aceituno Cubero, Gregorio Soto Rojas, Beatriz Girela Pérez, Sara Ballesteros Pradas, Virginia Pérez Ramírez, Almudena Valle Alberca, Susana Pérez Córdoba, José Javier Sánchez Fernández, Beatriz Calvo Bernal, Antonio Enrique Gómez Menchero, Carmen Lluch Requerey, Ana Del Río Lechuga, Juan José Serrano Silva, Rafael González González Manzanares, Dolores Mesa Rubio","doi":"10.1007/s12928-025-01237-z","DOIUrl":"https://doi.org/10.1007/s12928-025-01237-z","url":null,"abstract":"<p><p>There are no \"real world\" data on the actual impact of percutaneous left atrial appendage closure (LAAC) programs in the management of anticoagulated patients with atrial fibrillation (AF) after a hospital admission for bleeding. Our aim was to investigate the frequency, associated factors and prognostic impact of LAAC in the management of this population. All anticoagulated AF patients discharged alive from January 2021 to December 2022 after an intracranial or gastrointestinal haemorrhage, in the 15 public hospitals with LAAC program in Andalusia (South of Spain) were included in the study. Frequency, associated factors and prognostic impact of LAAC were investigated. Among a population of 7.119.044 inhabitants, 1403 patients were included (median age 81[p25-75, 76-87] years, 51.6% male). A LAAC procedure was performed in 114 patients (8.13%, 95%CI 6.70-9.56%) at 5 [2-10] months after discharge. LAAC was independently associated with tertiary referral centre, intracranial haemorrhage, previous bleeding, valvular heart disease, leukaemia and aspirin use while it was more infrequent in aged > 80 years, dementia, uncontrolled hypertension, vitamin K antagonist use and interventional treatment of the bleeding event (p < 0.05). After the procedure, the LAAC group had a better survival free from embolic/bleeding events and all-cause death (66% versus 49%) and overall survival (82% versus 64%) at 24 months (p < 0.05), consistent after multivariate adjustment: HR 0.65[0.46-0.92] and HR 0.52[0.32-0.86], respectively (p < 0.05). In our study, LAAC was infrequently performed after a severe bleeding in anticoagulated AF patients, although it was associated with better prognosis.</p>","PeriodicalId":9439,"journal":{"name":"Cardiovascular Intervention and Therapeutics","volume":" ","pages":""},"PeriodicalIF":5.8,"publicationDate":"2026-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146112514","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
{"title":"Distal embolism due to suspicious plaque shifting from superficial to deep femoral artery.","authors":"Tetsuya Nomura, Mai Imanaka, Naoki Nishimura, Hiroshi Kubota, Yukinori Kato, Naotoshi Wada","doi":"10.1007/s12928-026-01246-6","DOIUrl":"https://doi.org/10.1007/s12928-026-01246-6","url":null,"abstract":"","PeriodicalId":9439,"journal":{"name":"Cardiovascular Intervention and Therapeutics","volume":" ","pages":""},"PeriodicalIF":5.8,"publicationDate":"2026-02-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146112453","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}